CHEK1 and medulloblastoma: Furthermore, we demonstrated that inhibition of CHK1 by small molecule inhibitors AZD7762 and PF477736 as well as genetic knockdown of CHK1 in medulloblastoma cell lines results in decreased proliferation both in short and long-term assays.